Mesh safety review highlights failures in women’s healthcare
Mesh safety review highlights failures in women’s healthcare (new scientist)
https://images.newscientist.com/wp-content/uploads/2020/07/07150514/07-july_pelvic-mesh-report.jpg?width=778
- A recent UK government sponsored study (Independent Medicines and Medical Devices Safety Review) reviewed how the UK healthcare system handled concerns over pelvic mesh surgery, the historic use of hormonal pregnancy tests & an epilepsy treatment (sodium valproate) IMMD safety review report.
- Titled First Do No Harm, it comes after what the committee describe as “a two-year review of harrowing patient testimony and a large volume of other evidence concerning three medical interventions: Primodos, sodium valproate and pelvic mesh”. The committee chair was quoted as saying “I am sorry to say that in too many cases concerning Primodos, sodium valproate and pelvic mesh, our system has failed in its responsibilities**. We met with people, more often than not women, whose worlds have been turned upside down, their whole lives, and often their children’s lives, shaped by the pain, anguish and guilt they feel as the result of Primodos, sodium valproate or pelvic mesh.“
- The review came up with nine major recommendations, including the establishment of a Redress Agency & reforms of the processes followed by the regulator of medicines and medical devices & the General medical Council.
Analysis and comments
While the report does not appear to directly say (its 277 pages long) that these issues arose, at least in part, because these treatments impacted women, it is implicit in some of the key issues they highlight. This one stood out… “Some clinicians’ reactions ranged from ‘it’s all in your head’ to ‘these are women’s issues’ or ‘it’s that time of life’ wherein anything and everything women suffer is perceived as a natural precursor to, part of, or a post-symptomatic phase of, the menopause”*
-
Coincidently, around the same time Forbes published a long article women's healthcare market ripe for disruption on the potential for disruption in women’s healthcare. This covers areas as diverse as oncology, bone health, heart disease & brain health, in addition to the “traditional women’s health issues” of gynaecological & reproductive health. The article highlights the differences between male & female physiology, and how this impacts different rates of heart disease and autoimmune conditions.**
➡️ Publish0x ➡️ UpTrennd ➡️ Minds ➡️ Hive ➡️ Twitter ➡️ Facebook ➡️ Be paid daily to browse with Brave Internet Browser ➡️ A secure and easy wallet to use: Atomic Wallet
Proud member of:
**
20% of this article rewards wil go to the @ph-fund account in order to support HODL Community Initiatives.
**
**
Find out more about HODL Community: Crypto Social Community and by following our community account @hodlcommunity
**
Helps us by delegating to @hodlcommunity
If you would like to delegate some HP to our community and support us; we give you back 90% of the curation rewards on a daily basis ! APR > 13% !
Make a good APR Curation by following our HIVE trail here
